Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pivotal Therapeutics Inc PVTTF

Healthcare Drug Manufacturers - Specialty & Generic
Pivotal Therapeutics Inc is a Canada based pharmaceutical company. It focuses on Omega-3 therapies for cardiovascular disease and overall health. The products of the company are VASCAZEN which is a prescription-only medical food for the treatment of an Omega-3 Deficiency in patients with cardiovascular disease, OMAZEN, and BENEFISHIAL which provides pure Omega-3 fatty acids for the maintenance of health. The firm operates in the United States and Canada of which majority of the revenue is derived from the United States.


GREY:PVTTF - Post by User

Pivotal Therapeutics Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by BAMitchellon Nov 10, 1999 4:02pm
77 Views
Post# 1070329

RE: PVO

RE: PVO(I like the bids) support is at 58 which is the mid point for the stock price for the year .I think this could be the support level. Thanks to other posters for the updates . Now what we need is a increase in volume. Bruce
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities